Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA announce seventh case of morphine
racehorse
BHA have received analysis reporting the findings and the trainers involved have been informed.

Two further post-race samples found to contain morphine, bringing total to seven

The British Horseracing Authority (BHA) has been notified that two further post-race samples, obtained from recent race meetings, have been found to  contain morphine - a prohibited substance on raceday.

The two horses are under the care of two separate trainers. BHA have received analysis reporting the findings and the trainers involved have been informed.

BHA say that they will not make public any information regarding the identity of the horses, trainers or owners until all necessary processes are completed. This includes counteranalysis of respective "B" samples requested by those connected with the horses, and the BHA's own investigations.

In total, seven horses under the care of various trainers have now been reported to show the presence of the drug in their "A" samples.

The BHA have not ruled out the reporting of further positive detections from post-race samples obtained in recent weeks. The authority are continuing to investigate any link between the individual cases and are working closely with the British Equine Trade Association, the National Trainers Federation and the trainers of the horses in question.

Once all processes have been completed, the cases will be put before a disciplinary panel who will consider the matters before deciding what action, if any, should be taken. This may include the disqualification of the horses in question from the relevant races. 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'